Leveraging a disulfidptosis-based signature to improve the survival and drug sensitivity of bladder cancer patients
Article in Frontiers in Immunology (May 2023)
The most recent citing publications are shown below. View all 7 publications that cite this research output on Dimensions.
N6-methyladenosine-associated prognostic pseudogenes contribute to predicting immunotherapy benefits and therapeutic agents in head and neck squamous cell carcinoma
Article in Theranostics (October 2022)
Development and validation of a m6A -regulated prognostic signature in lung adenocarcinoma
Article in Frontiers in Oncology (October 2022)